Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 04 - 12    source : Www.biospace.com    save search

STRATA Skin Sciences Appoints William D. Humphries to Its Board of Directors
Published: 2021-04-12 (Crawled : 01:00) - biospace.com/
BHC | $8.66 -0.92% 0.0% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.71% H: 0.0% C: -2.0%
SSKN | $0.529 6.33% 5.95% 45K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 2.47% C: 2.47%

skin
AbCellera to Present Virtually at Upcoming Investor Conferences
Published: 2021-04-12 (Crawled : 01:00) - biospace.com/
ABCL | $3.92 -3.21% -3.32% 1.1M twitter stocktwits trandingview |
| | O: -0.83% H: 2.01% C: -0.69%

conference presentation
Guardant Health to Report First Quarter Financial Results on May 6, 2021
Published: 2021-04-12 (Crawled : 01:00) - biospace.com/
GH M | $16.4 1.49% 1.46% 1.5M twitter stocktwits trandingview |
Health Services
| | O: -1.02% H: 0.87% C: -0.37%

financial results results health
Shockwave Medical to Report First Quarter 2021 Financial Results on May 10, 2021
Published: 2021-04-12 (Crawled : 01:00) - biospace.com/
SWAV | $327.5 0.0% 1M twitter stocktwits trandingview |
Health Technology
| | O: -0.75% H: 0.68% C: -3.27%

financial results results
Trxade Group to Report First Quarter 2021 Financial Results on Monday, April 26th at 5:00 p.m. Eastern Time
Published: 2021-04-12 (Crawled : 01:00) - biospace.com/
MEDS | $7.36 4.25% 4.08% 52K twitter stocktwits trandingview |
Commercial Services
| | O: 1.98% H: 0.0% C: -3.31%

financial results results
Innovent and Lilly Release Phase 3 Results of TYVYT® (Sintilimab Injection) as a Second-Line Treatment for Squamous Non-Small Cell Lung Cancer at AACR Annual Meeting 2021
Published: 2021-04-12 (Crawled : 01:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.57% H: 0.28% C: -0.88%

treatment lung cancer injection results cancer phase 3
Amarin Announces CEO Succession Plan
Published: 2021-04-12 (Crawled : 00:00) - biospace.com/
AMRN | News | $0.9249 3.24% 3.14% 880K twitter stocktwits trandingview |
Health Technology
| | O: 0.08% H: 0.0% C: -1.6%

ceo leo
Marinus Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-04-12 (Crawled : 00:00) - biospace.com/
MRNS | $1.45 20.83% 17.24% 10M twitter stocktwits trandingview |
Health Technology
| | O: 0.32% H: 0.0% C: -10.15%

granted grant
Astrotech Announces Closing of $37.3 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
Published: 2021-04-12 (Crawled : 00:00) - biospace.com/
ASTC | $9.74 0.21% 1.5K twitter stocktwits trandingview |
Electronic Technology
| | O: -0.68% H: 1.37% C: -17.12%

offering
Maravai LifeSciences Announces Closing of Secondary Offering of Class A Common Stock by Selling Stockholders and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Published: 2021-04-12 (Crawled : 00:00) - biospace.com/
MRVI F | $7.71 -5.28% -5.58% 1.8M twitter stocktwits trandingview |
Commercial Services
| | O: -0.63% H: 2.64% C: 1.57%
MS | News 0 d | $90.08 1.06% -0.28% 9.5M twitter stocktwits trandingview |
Finance
| | O: 0.28% H: 0.15% C: -0.95%

offering
Crinetics Pharmaceuticals Announces Closing of Common Stock Offering
Published: 2021-04-12 (Crawled : 00:00) - biospace.com/
CRNX | $44.04 1.27% 1.25% 510K twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 1.47% C: 0.59%

offering
Seer to Report First Quarter Financial Results on May 10, 2021
Published: 2021-04-12 (Crawled : 00:00) - biospace.com/
SEER | $1.69 -3.43% -3.55% 380K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -0.6% H: 5.28% C: 3.62%

financial results results
Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021
Published: 2021-04-12 (Crawled : 00:00) - biospace.com/
ADPT | News | $2.435 -11.46% -12.94% 3.3M twitter stocktwits trandingview |
Commercial Services
| | O: 0.59% H: 0.84% C: -1.2%

financial results results biotech iot
Bioventus to Release First Quarter of Fiscal Year 2021 Financial Results on May 12, 2021
Published: 2021-04-12 (Crawled : 00:00) - biospace.com/
BVS S | $4.7 1.29% 1.28% 130K twitter stocktwits trandingview |
| | O: 0.07% H: 2.62% C: 0.29%

financial results results
Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results
Published: 2021-04-12 (Crawled : 00:00) - biospace.com/
SLP | News | $44.82 -1.19% -1.2% 82K twitter stocktwits trandingview |
Technology Services
| | O: 1.7% H: 2.41% C: -0.05%

financial results results
Celcuity Presents Data at AACR Annual Meeting Assessing Gedatolisib
Published: 2021-04-12 (Crawled : 00:00) - biospace.com/
CELC | $16.96 -1.57% -1.59% 120K twitter stocktwits trandingview |
Commercial Services
| | O: -2.78% H: 33.05% C: 33.05%

presentation
Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA™ COVID-19 Vaccine Candidate in Felines
Published: 2021-04-12 (Crawled : 20:00) - biospace.com/
APDN | $0.3295 -4.3% -4.49% 84K twitter stocktwits trandingview |
Commercial Services
| | O: -0.42% H: 10.47% C: -6.22%

covid positive results vaccine trial
Novartis receives FDA approval of Xolair® (omalizumab) self-injection with prefilled syringe across all indications for appropriate patients
Published: 2021-04-12 (Crawled : 20:00) - biospace.com/
NVS | News | $93.08 -0.13% 0.86% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.38% H: 0.49% C: 0.14%

fda fda approval injection approval
BeiGene Presents Interim Analysis Results of RATIONALE 303 Trial of Tislelizumab in Second- or Third-Line Non-Small Cell Lung Cancer at the AACR Annual Meeting 2021
Published: 2021-04-12 (Crawled : 20:00) - biospace.com/
BGNE S | $131.885 -1.62% -1.64% 200K twitter stocktwits trandingview |
Health Technology
| | O: 0.09% H: 0.0% C: -4.44%
AMGN | $264.07 -0.59% -0.59% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 0.6% C: 0.17%

lung cancer results cancer trial
Zynex Announces 140% Year over Year Order Growth in Q1-2021
Published: 2021-04-12 (Crawled : 18:00) - biospace.com/
ZYXI | $12.075 -0.62% -0.62% 100K twitter stocktwits trandingview |
Health Technology
| | O: -0.13% H: 1.22% C: -2.11%

growth order
Gainers vs Losers
56% 44%

Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M twitter stocktwits trandingview |
Health Technology

SINT | $0.0365 59.39% 37.26% 470M twitter stocktwits trandingview |
Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M twitter stocktwits trandingview |
Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M twitter stocktwits trandingview |

GCTK | $0.715 36.27% 26.62% 640K twitter stocktwits trandingview |
Manufacturing

TCON | $2.33 36.26% 26.61% 2M twitter stocktwits trandingview |
Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M twitter stocktwits trandingview |

KZIA | $0.38 30.58% 23.42% 300K twitter stocktwits trandingview |
Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M twitter stocktwits trandingview |
Health Technology

ATNF | $1.91 29.05% 22.51% 310K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.